|
Effect of parathyroidectomy on insulin resistance and microinflammatory status in uremic patients with secondary hyperparathyroidism
2019, 18 (05):
291-294.
doi: 10.3969/j.issn.1671-4091.2019.05.001
【Abstract】Objective To observe the effect of parathyroidectomy with forearm autograft (PTX+AT) on insulin resistance and microinflammatory status in uremic patients with secondary hyperparathyroidism. Methods A total of 38 uremic patients with secondary hyperparathyroidism but without diabetes undergoing PTX+AT in the period from March 2017 to June 2108 in Guangzhou Panyu Central Hospital were retrospectively analyzed. Their intact parathyroid hormone (iPTH), blood phosphate (P), blood cholesterol (CH), triglyceride (TG), low density lipoprotein (LDL), high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6) and tumor necrosis factor Q (TNF-Q), fasting blood glucose (FBG) and fasting blood insulin (FINS) were compare before and after PTX+AT. Results ① After PTX+AT for 3 months, CH, TG , LDL, P and iPTH decreased significantly (t=-3.717, -2.261, -3.980, -3.541 and -9.807 respectively; P=0.013, 0.039, 0.011, 0.019 and <0.001 respectively) as compared to those before PTX+AT. After PTX+AT for 6 months, CH, TG, LDL, P and iPTH decreased significantly (t=-4.023, -2.097, -4.106, -4.004 and -9.921 respectively; P=0.009, 0.040, 0.010, 0.011 and <0.001 respectively) as compared to those before PTX+AT, but without statistical signifi-cance (t=-0.080, 0.376,-0.004, -0.055 and 1.043 respectively; P=0.058, 0.072, 0.064, 0.059 and 0.088 respectively) as compared to those after PTX+AT for 3 months. ② After PTX+AT for 3 months, hs-CRP, IL-6, TNFɑ and the insulin resistance index (IR) decreased significantly (t=-1.096, -1.849, -2.396 and -2.887 respectively; P=0.038, 0.028, 0.015, and 0.045 respectively) as compared to those before PTX+AT. After PTX+AT for 6 months, hs-CRP, IL-6, TNF-Q and IR decreased significantly (t=-2.315, -2.421, -3.225 and -3.000 respectively; P=0.027, 0.019, 0.006 and 0.037 respectively) as compared to those before PTX+AT; hs-CRP, IL-6 and TNF-Q decreased significantly (t=-2.011, -2.376 and -3.333 respectively; P=0.031, 0.022 and 0.005 respectively) but IR had no significant change (t=-0.006; P=0.679) as compared to those after PTX+AT for 3 months.
Conclusion PTX+AT is effective to treat severe secondary hyperparathyroidism in uremic patients, which can also improve microinflammation, IR and derangement of lipid metabolism.
Metrics
|